Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cross The Ages (CTA) vs Enzyme (MLN) Price & Performance

Cross The AgesTrade
EnzymeTrade

Price performance (Past 24H)

Key statistics

Cross The Ages vs Enzyme — how do they compare? Cross The Ages trades at Rp13.85 (market cap Rp6,87M, Rp233,56jt 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 19.5× Cross The Ages's market cap, and Cross The Ages's supply is capped (500M / 500M CTA (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Cross The Ages for 7 Days and Enzyme for 28 Days on average.

CTAMLN
Market Cap
Rp6,87MRp134,13M
Volume (24h)
Rp233,56jtRp104,56M
Circulating Supply
500M / 500M CTA (100%)3,3M MLN
Typical Hold Time
7 Days28 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cross The Ages

Cross The Ages (CTA) is currently trading at Rp14,037 with a bearish technical signal, showing selling pressure in moving averages but neutral oscillators. The token has 100% circulating supply of 500 million CTA, with key support at Rp13 and resistance at Rp17. Recent analysis highlights its role in managed futures strategies, though news primarily discusses ETF contexts rather than direct crypto developments.

Overall outlook is cautious due to bearish technicals and limited crypto-specific updates. Opportunities include potential rebounds from support levels, but risks involve low liquidity (market cap Rp6.9M) and mixed sentiment. Investors should monitor on-chain activity and regulatory shifts in crypto markets.

Enzyme

Enzyme (MLN) shows a market cap of Rp134,13M with a circulating supply of 3,3jt tokens. The asset's price data is currently unavailable, but the hold time of 28 days suggests moderate trader retention. Recent news on ETF inflows may indirectly affect crypto sentiment, though no direct protocol updates are noted. Trading volumes and network activity metrics require verification from live crypto data sources for a complete picture.

Outlook: Enzyme faces typical crypto volatility risks with limited recent fundamental developments. Opportunities may arise from broader market trends, but investors should monitor liquidity and regulatory shifts closely. Major risks include low market cap susceptibility to manipulation and absence of max supply clarity.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTA
84% Buy16% Sell
Avg holding period · 7 Days
MLN

No sentiment data available yet.

About Cross The Ages

Cross The Ages (CTA) is a multimedia IP spanning video games, books, films, collectibles, and more, blending Web2 and Web3 ecosystems. It creates an expansive universe that engages its community through diverse experiences and entertainment.

Read more on CTA

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN